ReviewExpert review of vaccines2017
Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
Review in Expert review of vaccines, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Immunogenicity and safety of novel oral polio vaccine type 2 (nOPV2) in pediatric populations: a systematic review and Bayesian meta-analysis.BMC infectious diseases · 2026Pooled it
- Reducing parents' vaccination hesitancy: a new educational training model in Turkish sample.Frontiers in public health · 2026Article
- New approaches to measles eradication, with special reference to Africa.The Pan African medical journal · 2025Article
- On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000-2023, Namibia.Vaccines · 2024Article
- Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.Vaccine · 2024Article
- Assessment of immunization session practices in primary health care centers in Al-Najaf province.Journal of public health in Africa · 2023Article
- The role of polio emergency operations centers: perspectives for future disease control initiatives in Nigeria.The Pan African medical journal · 2023Review
- Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis.Vaccine: X · 2022Article
- Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.Nature communications · 2022Article
- Policy and practice of checking vaccination status at school in 2018, a global overview.Vaccine · 2022Article
- Some lessons for malaria from the Global Polio Eradication Initiative.Malaria journal · 2021Review
- Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.Vaccine · 2020Article
- A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.Current opinion in virology · 2020Review
- Article
- Recent setbacks in measles elimination: the importance of investing in innovations for immunizations.The Pan African medical journal · 2020Article
- Global trends in measles publications.The Pan African medical journal · 2020Review
- Article
- Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands.Nature communications · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
introductionIn 1988, an estimated 350,000 children were paralyzed by polio and 125 countries reported polio cases, the World Health Assembly passed a resolution to achieve polio eradication by 2000, and the Global Polio Eradication Initiative (GPEI) was established as a partnership focused on eradication. Today, following eradication efforts, polio cases have decreased >99% and eradication of all three types of wild polioviruses is approaching. However, since polio resources substantially support disease surveillance and other health programs, losing polio assets could reverse progress toward achieving Global Vaccine Action Plan goals. Areas covered: As the end of polio approaches and GPEI funds and capacity decrease, we document knowledge, experience, and lessons learned from 30 years of polio eradication. Expert commentary: Transitioning polio assets to measles and rubella (MR) elimination efforts would accelerate progress toward global vaccination coverage and equity. MR elimination feasibility and benefits have long been established. Focusing efforts on MR elimination after achieving polio eradication would make a permanent impact on reducing child mortality but should be done through a 'diagonal approach' of using measles disease transmission to identify areas possibly susceptible to other vaccine-preventable diseases and to strengthen the overall immunization and health systems to achieve disease-specific goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.